Robert McRae - 03 Apr 2023 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Role: Chief Operating Officer
Signature: /s/ Robert McRae
Issuer symbol: PALI
Transactions as of: 03 Apr 2023
Transactions value $: -$540
Form type: 4
Filing time: 05 Apr 2023, 18:52:42
Previous filing: 15 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PALI	Common Stock, par value $0.01	Options Exercise	$0	+655	+272.92%	$0.00	895	03 Apr 2023	Direct	F1
transaction	PALI	Common Stock, par value $0.01	Tax liability	-$540	-270	-30.17%	$2.00	625	03 Apr 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PALI	Restricted Stock Units	Options Exercise		-655	-25.02%		1.96K	03 Apr 2023	Common Stock	655		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.
F2	Represents shares withheld by Issuer to satisfy tax withholding requirements on vesting of restricted stock units.
F3	This restricted stock unit was granted on January 3, 2023, and 655 restricted stock units subject to the award vested on April 3, 2023, and approximately 654 restricted stock units are scheduled to vest on each of July 3, 2023, October 3, 2023, and January 3, 2023, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.